CD8A and infection: CD8+ T cells specific for the EBNA2-derived YHL epitope recognised EBV-infected B cells at the earliest assay time point, day 1 post-infection; similar results were obtained using CD8+ clones specific for a second EBNA2-derived epitope (RPT, Fig 6C).